|Articles|January 1, 2002

Supplements and Featured Publications

  • Symposium Reporter - Lipid Management
  • Volume 8
  • Issue 1 Symp

Risk Factors Common to Insulin Resistance and Atherosclerosis Explain Why Diabetes is a Cardiovascular Disease

Download PDF: Risk Factors Common to Insulin Resistance and Atherosclerosis Explain Why Diabetes is a Cardiovascular Disease

Articles in this issue

about 24 years ago

Cholesterol Goals Established for Patients with Diabetes and Metabolic Syndrome

about 24 years ago

Dyslipidemia of Insulin Resistance Syndrome Explained; Need for Treatment to Reduce Risk Emphasized

about 24 years ago

Review of Clinical trial Data Reaffirms Safety of Statin Therapy

about 24 years ago

Protective Effects of HDL-C and Need to Raise Low Levels Explored

about 24 years ago

Question and Answer

about 24 years ago

Heart Protection Study Finds Simvastatin Reduces Vascular Risk in a Wide Range of High-Risk Patients

about 24 years ago

Lipid-Lowering Therapy Stabilizes Plaque Reduces Events by Limiting Inflammation

about 24 years ago

New Cholesterol Guidelines Emphasize Risk Assessment

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs
Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

View more
Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care
AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

View more
Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text